Skeletal Muscle Contractility and Fatigability in Adults with Cystic Fibrosis
Overview
Authors
Affiliations
Background: Recent discovery of cystic fibrosis transmembrane conductance regulator expression in human skeletal muscle suggests that CF patients may have intrinsic skeletal muscle abnormalities potentially leading to functional impairments. The aim of the present study was to determine whether CF patients with mild to moderate lung disease have altered skeletal muscle contractility and greater muscle fatigability compared to healthy controls.
Methods: Thirty adults (15 CF and 15 controls) performed a quadriceps neuromuscular evaluation using single and paired femoral nerve magnetic stimulations. Electromyographic and mechanical parameters during voluntary and magnetically-evoked contractions were recorded at rest, during and after a fatiguing isometric task. Quadriceps cross-sectional area was determined by magnetic resonance imaging.
Results: Some indexes of muscle contractility tended to be reduced at rest in CF compared to controls (e.g., mechanical response to doublets stimulation at 100 Hz: 74±30 Nm vs. 97±28 Nm, P=0.06) but all tendencies disappeared when expressed relative to quadriceps cross-sectional area (P>0.5 for all parameters). CF and controls had similar alterations in muscle contractility with fatigue, similar endurance and post exercise recovery.
Conclusions: We found similar skeletal muscle endurance and fatigability in CF adults and controls and only trends for reduced muscle strength in CF which disappeared when normalized to muscle cross-sectional area. These results indicate small quantitative (reduced muscle mass) rather than qualitative (intrinsic skeletal muscle abnormalities) muscle alterations in CF with mild to moderate lung disease.
Clayton L, Shepherd A, Corbett J, Gruet M, Connett G, Allenby M Pediatr Pulmonol. 2025; 60(3):e71044.
PMID: 40071679 PMC: 11898567. DOI: 10.1002/ppul.71044.
Chatain C, Vallier J, Paleiron N, Cucchietti Waltz F, Ramdani S, Gruet M Eur J Appl Physiol. 2024; 125(2):409-428.
PMID: 39305368 PMC: 11829911. DOI: 10.1007/s00421-024-05608-x.
Extrapulmonary manifestations of pulmonary arterial hypertension.
Singh N, Al-Naamani N, Brown M, Long G, Thenappan T, Umar S Expert Rev Respir Med. 2024; 18(3-4):189-205.
PMID: 38801029 PMC: 11713041. DOI: 10.1080/17476348.2024.2361037.
Ostadan F, Donovan A, Matouk E, David F, Marchand D, Reinhold C ERJ Open Res. 2023; 9(5).
PMID: 37753287 PMC: 10518894. DOI: 10.1183/23120541.00282-2023.
Relationship of muscle thickness, strength, and diaphragm function in adults with cystic fibrosis.
Uslu N, Kocakaya D, Olgun Yildizeli S, Eryuksel E, Coskun O, Cimsit C Turk J Phys Med Rehabil. 2023; 69(2):200-206.
PMID: 37671376 PMC: 10475901. DOI: 10.5606/tftrd.2023.10361.